IngentaConnect Search Results

Authors: Ruhstaller, T.; Widmer, L.; Schuller, J. C.; Roth, A.; Hess, V.; Mingrone, W.; von Moos, R.; Borner, M.; Pestalozzi, B. C.; BalmerMajno, S.; Kberle, D.; Terraciano, L.; Schnider, A.; Bodis, S.; Popescu, R.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1522-1528(7)

Publisher: Oxford University Press

Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival

Authors: Jarnagin, W. R.; Schwartz, L. H.; Gultekin, D. H.; Gnen, M.; Haviland, D.; Shia, J.; D'Angelica, M.; Fong, Y.; DeMatteo, R.; Tse, A.; Blumgart, L. H.; Kemeny, N.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1589-1595(7)

Publisher: Oxford University Press

Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma

Authors: Neyns, B.; Sadones, J.; Joosens, E.; Bouttens, F.; Verbeke, L.; Baurain, J.-F.; D'Hondt, L.; Strauven, T.; Chaskis, C.; In't Veld, P.; Michotte, A.; De Greve, J.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1596-1603(8)

Publisher: Oxford University Press

A randomized controlled trial of R-salbutamol for topical treatment of discoid lupus erythematosus

Authors: Jemec, G.B.E.; Ullman, S.; Goodfield, M.; Bygum, A.; Olesen, A.B.; Berth-Jones, J.; Nyberg, F.; Cramers, M.; Faergemann, J.; Andersen, P.; Kuhn, A.; Ruzicka, T.

Source: British Journal of Dermatology, Volume 161, Number 6, December 2009 , pp. 1365-1370(6)

Publisher: Blackwell Publishing

A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma

Authors: Gish, Robert; Gordon, Stuart; Nelson, David; Rustgi, Vinod; Rios, Israel

Source: Hepatology International, Volume 3, Number 3, September 2009 , pp. 480-489(10)

Publisher: Springer

Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial

Authors: Shindo, Michiko; Chayama, Kazuaki; Mochida, Satoshi; Toyota, Joji; Tomita, Eiichi; Kumada, Hiromitsu; Yokosuka, Osamu; Sata, Michio; Hayashi, Norio; Suzuki, Kazuyuki; Okanoue, Takeshi; Tsubouchi, Hirohito; Ishikawa, Hiroki; Seriu, Taku; Omata, Masao

Source: Hepatology International, Volume 3, Number 3, September 2009 , pp. 445-452(8)

Publisher: Springer

A call for more transparency of registered clinical trials on endometriosis

Authors: Guo, Sun-Wei; Hummelshoj, Lone; Olive, David L.; Bulun, Serdar E.; D'Hooghe, Thomas M.; Evers, Johannes L.H.

Source: Human Reproduction, Volume 24, Number 6, 3 June 2009 , pp. 1247-1254(8)

Publisher: Oxford University Press

Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial

Authors: Rivera, Fernando; García-Castaño, Almudena; Vega, Noelia; Vega-Villegas, Maria Eugenia; Gutiérrez-Sanz, Lourdes

Source: Expert Review of Anticancer Therapy, Volume 9, Number 10, October 2009 , pp. 1421-1428(8)

Publisher: Expert Reviews

Bayesian dose finding by jointly modelling toxicity and efficacy as time-to-event outcomes

Authors: Yuan, Ying; Yin, Guosheng

Source: Journal of the Royal Statistical Society: Series C (Applied Statistics), Volume 58, Number 5, November 2009 , pp. 719-736(18)

Publisher: Blackwell Publishing

Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group

Authors: Comella, Pasquale; Lorusso, Vito; Maiorino, Luigi; Casaretti, Rossana; Cannone, Michele; Massidda, Bruno; Putzu, Carlo; Leo, Silvana; Roselli, Mario; Mancarella, Sergio; Palmeri, Sergio; Greco, Ettore; Vessia, Giacomo; Sandomenico, Claudia; Franco, Luca

Source: Cancer Chemotherapy and Pharmacology, Volume 64, Number 5, October 2009 , pp. 893-899(7)

Publisher: Springer

Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer

Authors: Chang, Myung; Kim, Kyoung; Jun, Hyun; Kim, Hyo; Yi, Seong; Uhm, Ji; Park, Min; Lim, Do; Ji, Sang; Hwang, In; Lee, Jeeyun; Park, Yeon; Ahn, Jin; Ahn, Myung-ju; Park, Keunchil

Source: Cancer Chemotherapy and Pharmacology, Volume 64, Number 5, October 2009 , pp. 917-924(8)

Publisher: Springer

A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial

Authors: Pisano, Carmela; Morabito, Alessandro; Sorio, Roberto; Breda, Enrico; Lauria, Rossella; Gebbia, Vittorio; Scaltriti, Laura; Scalone, Simona; Zagonel, Vittorina; Greggi, Stefano; Beneduce, Gerardo; Losito, Simona; Gallo, Ciro; Maio, Massimo; Forestieri, Valeria; Pignata, Sandro

Source: Cancer Chemotherapy and Pharmacology, Volume 64, Number 5, October 2009 , pp. 1021-1027(7)

Publisher: Springer

Gemcitabine Plus Irinotecan as First-Line Weekly Therapy in Locally Advanced and/or Metastatic Pancreatic Cancer

Authors: Neri, B.; Cipriani, G.; Grifoni, R.; Molinara, E.; Pantaleo, P.; Rangan, S.; Vannini, A.; Tonelli, P.; Valeri, A.; Pantalone, D.; Taddei, A.; Bechi, P.

Source: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Volume 17, Numbers 11-12, 2009 , pp. 559-564(6)

Publisher: Cognizant Communication Corporation

Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia

Authors: Blum, Kristie A.; Advani, Anjani; Fernandez, Louis; Van Der Jagt, Richard; Brandwein, Joseph; Kambhampati, Suman; Kassis, Jeannine; Davis, Melanie; Bonfils, Claire; Dubay, Marja; Dumouchel, Julie; Drouin, Michel; Lucas, David M.; Martell, Robert E.; Byrd, John C.

Source: British Journal of Haematology, Volume 147, Number 4, November 2009 , pp. 507-514(8)

Publisher: Blackwell Publishing

Editorial [Hot topic: Gene Therapy Continues to Make Progress: Clinical and Regulatory Perspectives (Guest Editors: Maria G. Castro and Pedro R. Lowenstein)]

Authors: Castro, Maria G.; Lowenstein, Pedro R.

Source: Current Gene Therapy, Volume 9, Number 5, October 2009 , pp. 327-328(2)

Publisher: Bentham Science Publishers

Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial

Authors: Gebauer, K.; Shumack, S.; Cowen, P.S.J.

Source: British Journal of Dermatology, Volume 161, Number 4, October 2009 , pp. 897-903(7)

Publisher: Blackwell Publishing